JGC
YARW

J. Goldman & Co’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

J. Goldman & Co’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-11
Closed -$64K – 541
2020
Q4 		$64K Hold
11
– – ﹤0.01% 350
2020
Q3 		$68K Hold
11
– – ﹤0.01% 295
2020
Q2 		$71K Buy
11
+5
+83% +$33.9K ﹤0.01% 256
2020
Q1 		$54K Buy
+6
New +$94.1K 0.01% 229

Other funds holding YARW

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

J. Goldman & Co's YARW Position: Q1 2021 in Review

J. Goldman & Co sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q1 2021, closing a stake of 11 shares — an estimated $64K sold.

J. Goldman & Co first reported a position in YARW in Q1 2020 and held it in 4 quarters. The position peaked at $71K in Q2 2020. 81 funds tracked by Wall St. Rank hold YARW as of Q1 2021.

  • J. Goldman & Co reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • J. Goldman & Co sold 11 Yarrow Bioscience, Inc. Common Stock shares in Q1 2021, an estimated $64K.
  • J. Goldman & Co first reported a position in Yarrow Bioscience, Inc. Common Stock in Q1 2020 and held it in 4 quarters.
  • J. Goldman & Co's Yarrow Bioscience, Inc. Common Stock position peaked at $71K in Q2 2020.
  • 81 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2021.

Based on J. Goldman & Co's 13F filing for Q1 2021, filed 17 May 2021.